Farmak, a national pharmaceutical manufacturer, has signed a Memorandum of Understanding with the Ministry of Health of Ukraine. This document stipulates retention of wholesale prices for insulin preparations fixed as of 01 January 2014.
The Memorandum was signed by Oleg Musiy, Minister of Health of Ukraine, and the authorized representatives of 5 insulin manufacturers.
The document also envisages that the pharmaceutical manufacturers will ensure production and supply of a wide range of insulin preparations at the domestic pharmaceutical market, timely and full satisfaction of demand for such pharmaceutical products; cooperate in reducing the cost of such medicines for the public by aligning pharmacy prices with wholesale prices of manufacturers and suppliers, as well as ensure the formation of a transparent competitive environment based on compliance with the antitrust legislation.
In turn, the MOH undertakes to engage representatives of pharmaceutical public organizations in the preparation of draft Government decisions on state regulation of insulin prices by setting a threshold level of wholesale prices for these preparations based on comparative (reference) prices and the introduction of a cost reimbursement system, as well as development and conduct (by 01 September 2014) of a public discussion of these projects, and publication of threshold levels of wholesale prices for insulin preparations by 01 January 2015.
As part of the celebration of the 60th anniversary of the first release of Corvalol manufactured by Farmak, leader of the Ukrainian pharmaceutical market, the Ukrainian Book of Records has recognized Corvalol by Farmak as the most known sedative in Ukraine. Corvalol by Farmak is a globally known medicinal product that has already become a […]
On Sunday, February 24, the final matches within UFAM League 3rd season (Kyiv Open Futsal Championship among health care institutions) took place. The tournament which started at the end of 2018 was ended with the great sport and health event. 12 teams participated in the competition this year, including the players from the Cardiology Institute, Kyiv [&hell...
Компанія зайняла перше місце серед найбільших компаній у рейтингу «Виробництво ліків» Також ПАТ «Фармак» увійшов до рейтингів: «Рейтинг найбільших експортерів», «Рейтинг найбільших платників податків», «Рейтинг компаній по об’єму виручки». ПАТ «Фармак» – національний виробник лікарських засобів європейського ринку. Завдяки високій якості продукції та ...